Cardiac magnetic resonance imaging to detect ischemia in chronic coronary syndromes - state of the art.
The new '2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes' emphasize the role of non-invasive functional imaging of myocardial ischemia in diagnosing coronary artery disease to guide decision regarding revascularization. Cardiac magnetic resonance (CMR) stands out relative to other imaging modalities given its high safety profile, absence of ionizing radiation and its versatility in encoding various image contrasts. CMR allows to assess myocardial function, ischemia, viability and permits tissue characterization including detection of edema in a single examination. In recent years a number of meta-analyses and studies considering the role of CMR for detecting ischemia has been published. The recent multi-center, randomized MR-INFORM trial has demonstrated the clinical utility of CMR in patients with stable angina and cardiovascular risk factors. This landmark study has proven that perfusion CMR- based strategy leads to lower numbers of revascularizations while being non-inferior to an invasive coronary angiography with fractional flow reserve- guided therapy in terms of major adverse cardiac events at 1 year. In light of recent and future technical improvements, CMR will further extend its importance in the assessment of myocardial ischemia in patients with chronic coronary syndromes.